PROJECT ADDENDUMProject Addendum • March 12th, 2015 • Galectin Therapeutics Inc • Pharmaceutical preparations • North Carolina
THIS PROJECT ADDENDUM (the “Project Addendum”) is made and entered into as of January 10, 2015 (the “Effective Date”) by and between PPD DEVELOPMENT, LP, a Delaware limited partnership, with its principal executive offices located at 929 North Front Street, Wilmington, North Carolina 28401 (“PPD”) and GALECTIN THERAPEUTICS, INC., a Nevada corporation with its principal executive offices located at 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, Georgia 30071 (“Sponsor”).
